의료기술 인사이트

The European large-joint reconstructive implant market is poised for long-term expansion, driven by the adoption of innovative technologies like patient-conforming and 3-D printed implants, smart…

Given the urgent nature of the procedures within the trauma device market, the impact of the COVID-19 pandemic was less severe and the recovery was relatively fast for the Latin American trauma…

The biosurgical agent market in Latin America will observe modest growth through 2033, primarily driven by the increasing number of procedures utilizing biosurgical agents, combined with favorable…

The Latin American CRM device market will be driven by the expanding patient pool and improving access to treatment in Latin American countries. The market will experience modest growth through…

The European market for breast implants and reconstruction devices will exhibit modest growth, driven by several key factors. The safety and aesthetic results of breast augmentation and…

The Asia Pacific biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by the growing number of procedures in which in biosurgical agents are…

The European dialysis access treatment device market will grow modestly, mainly because of the increasing adoption of percutaneous AVF for dialysis access creation and DCBs for dialysis…

The Japanese biosurgical agent market will exhibit moderate growth over the forecast period. Growth over the forecast period will be driven by continuing growth of procedures in which in…

Over the forecast period, Latin American spinal implant market expansion will be driven by procedure volume growth due to an aging population and uptake of premium innovations such as 3-D–printed…

The Latin American EP mapping and ablation device market will experience strong growth as a result of favorable demographic trends, increasing ablation procedure volumes and the introduction of…

The US biopsy device market has shown strong recovery from the impacts of the COVID-19 pandemic and is anticipated to resume prepandemic growth trends in the near term, with subsequent slow growth…

The biosurgical agent market in Latin America will observe modest growth through 2032, primarily driven by surgical procedure volume growth, increasing evidence of the clinical benefits of…